Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MKC-1 in advanced pancreatic cancer
NCT00568646Phase 2Completed
- Sponsor
- CASI Pharmaceuticals, Inc.
- Start
- Nov 2007
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mkc-1 in pancreatic cancer (PC), sponsored by CASI Pharmaceuticals, Inc.. Started Nov 2007; status: completed.
02
Drugs
mkc-1
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00568646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568646.